QNCX
Quince Therapeutics, Inc.
-0.17 (-0.63%)27.00USD4.4K成交股數27.5M市值0.4本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.5M | 6.8M | 12.6M | 8.1M | 6.6M | 8.1M | 4.9M | 4.1M | 3.7M | 3.4M | 1.4M | 1.4M |
| 銷售管理費用 | 16.6M | 4.3M | 3.6M | 3.3M | 3.3M | 4.8M | 3.6M | 4.7M | 5.0M | 5.0M | 4.7M | 4.2M |
| 營業利益 | −79.8M+665% | −14.6M-2% | −19.4M+230% | −13.4M-52% | −10.4M-7% | −14.9M+49% | −5.9M-4% | −28.2M+405% | −11.2M | −10.0M | −6.1M | −5.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −75.5M+370% | 35.9M-339% | −39.5M+618% | −13.4M-52% | −16.0M+44% | −15.0M+69% | −5.5M+3% | −27.7M+468% | −11.1M | −8.9M | −5.4M | −4.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -12.31-82% | 2.88-184% | 70.74-54515% | -0.25-61% | -68.75+26342% | -3.42+1529% | -0.13-13% | -0.64+357% | -0.26 | -0.21 | -0.15 | -0.14 |
| 稀釋股數 | 6.1M | 9.2M | 50.1M | 54.0M | 233K | 4.4M | 43.2M | 43.1M | 43.0M | 37.2M | 36.1M | 35.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 116M | 18.2M | 5.8M | 6.5M | 16.8M | 7.8M | 2.7M | 7.9M | 21.8M | 20.8M | 20.8M | 20.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | 500K | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 124M | 26.6M | 93.5M | 110M | 117M | 107M | 127M | 135M | 159M | 168M | 85.4M | 88.8M |
| 有息負債 | – | – | 0.00 | 0.00 | 17.0M | 15.3M | 14.9M | 13.8M | 13.5M | 13.4M | – | – |
| 總負債 | 15.5M | 11.0M | 129M | 109M | 105M | 88.5M | 81.6M | 87.9M | 85.1M | 82.8M | 2.3M | 2.0M |
| 股東權益 | −35.3M | 15.7M | −35.7M | 1.1M | 11.7M | 18.6M | 44.9M | 47.0M | 74.2M | 85.1M | 83.1M | 86.9M |
| 負債比 | 12.5% | 41.1% | 138.2% | 99.0% | 90.0% | 82.6% | 64.5% | 65.2% | 53.4% | 49.3% | 2.6% | 2.2% |
| 淨現金(現金 − 有息負債) | – | – | 5.8M | 6.5M | −163K | −7.5M | −12.2M | −5.9M | 8.3M | 7.3M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.6M-21% | – | – | – | −9.6M | – | – | −8.4M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 148K | – | – | 39K | – | – | – |
| 自由現金流 | – | −7.6M-22% | – | – | – | −9.7M | – | – | −8.4M | – | – | – |
| 折舊攤銷 | – | 36K | – | – | – | 32K | – | – | 40K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −84.0M | –% | -1.68 | −41.8M |
| FY2024 | – | – | −56.8M | –% | -1.31 | −32.2M |
| FY2023 | – | – | −31.4M | –% | -0.84 | −18.5M |
| FY2022 | – | – | −51.7M | –% | -1.54 | −44.2M |
| FY2021 | – | – | −89.9M | –% | -3.03 | −63.1M |
| FY2020 | – | – | −76.8M | –% | -2.63 | −50.9M |
| FY2019 | – | – | −37.0M | –% | -1.94 | −33.3M |
| FY2018 | – | – | −12.5M | –% | -3.71 | −11.9M |